1. Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods 
C. Muller-Serieys, H.B. Drugeon, J. Etienne, C. Lascols, R. Leclercq, J. Nguyen, C.J. Soussy 
Clinical Microbiology and Infection 
Volume 10, Issue 3, Pages (March 2004)
DOI: /j X x
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Distribution of MICs of linezolid against S. aureus (n = 296) by agar dilution (method A) and broth microdilution (method B).
Clinical Microbiology and Infection  , DOI: ( /j X x)
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

3. Fig. 2
Distribution of MICs of linezolid against coagulase negative staphylococci (n = 200) by agar dilution (method A) and broth microdilution (method B).
Clinical Microbiology and Infection  , DOI: ( /j X x)
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

4. Fig. 3
Distribution of MICs of linezolid against enterococci by agar dilution (method A) and broth microdilution (method B).
Clinical Microbiology and Infection  , DOI: ( /j X x)
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

5. Fig. 4
Distribution of MICs of linezolid against S. pneumoniae (n = 118) by agar dilution (method A) and Etest (method E).
Clinical Microbiology and Infection  , DOI: ( /j X x)
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

6. Fig. 5
Distribution of MICs of linezolid against other streptococci (n = 30) by agar dilution (method A) and Etest (method E).
Clinical Microbiology and Infection  , DOI: ( /j X x)
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions